HAEM5:Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 893: | Line 893: | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
|- | |- | ||
|[[HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | |[[HAEM5:Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm|Mature plasmacytoid dendritic cell proliferation associated with myeloid neoplasm]] | ||
| Line 1,087: | Line 1,099: | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
|- | |- | ||
|[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | |[[HAEM5:Reactive B-cell rich lymphoid proliferations that can mimic lymphoma|Reactive B-cell rich lymphoid proliferations that can mimic lymphoma]] | ||
| Line 2,022: | Line 2,045: | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
|- | |- | ||
|Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK) | |Kikuchi-Fujimoto disease||Disease|| || || || || ||Sumi Kitahara (SK) | ||
| Line 2,332: | Line 2,367: | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
|- | |- | ||
|Follicular dendritic cell sarcoma | |Follicular dendritic cell sarcoma | ||
| Line 2,462: | Line 2,509: | ||
----<br /> | ----<br /> | ||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
| | | | ||
----<br /> | |||
|- | |- | ||
|Fanconi anaemia||Disease|| || || || || ||NA|| || | |Fanconi anaemia||Disease|| || || || || ||NA|| || | ||